Terumo
Terumo Corporation was created in 1921 in Tokyo, Japan, with the goal of producing clinical thermometers and other critical medical instruments that the country could no longer import after World War I. In 2021, the firm will produce a wide range of medical items, ranging from stents and catheters under its cardiovascular divisions to blood collection and infusion systems, patient monitoring, and hypodermics under its other divisions. Terumo's annual sales were $5.8 billion in 2020, and the company presently employs over 26,400 people worldwide.
They are a U.S. subsidiary of Terumo Corporation, located in Tokyo, and sell products in one of four business divisions:
- Terumo Interventional Systems: A market leader in minimally invasive entry site management, lesion access, and interventional technologies including stents, balloons, and sheaths, among other things
- Terumo Medical Products: In both the human and animal health industries, the company creates injectable and infusion treatment devices that enable doctors to provide the finest day-to-day care to their patients.
- Terumo Pharmaceutical Solutions: clients and their patients with medicine delivery systems that are simple and comfortable.
- Terumo Business Edge: a strategic business partner that assists healthcare organizations in reducing treatment variance, improving quality metrics, lowering costs, and increasing income.
Founded: 1972
Headquarters: Somerset, New Jersey
Website: https://www.terumomedical.com/
